ChemDiv 
Welcome,         Profile    Billing    Logout  
 1 Product   0 Diseases  1 Product   1 Trial   6 News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AV5080 / Viriom
NCT05093998: Study Evaluating the Efficacy and Safety of AV5080 in Patients With Uncomplicated Influenza

Not yet recruiting
3
700
RoW
AV5080, AV5080 at a daily dose of 160 mg, Placebo
Viriom
Influenza
07/23
07/23
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
AV5080 / Viriom
NCT05093998: Study Evaluating the Efficacy and Safety of AV5080 in Patients With Uncomplicated Influenza

Not yet recruiting
3
700
RoW
AV5080, AV5080 at a daily dose of 160 mg, Placebo
Viriom
Influenza
07/23
07/23

Download Options